Study at a glance
What was studied?
Researchers compared vitamin D supplementation strategies in infants. Some infants were born at term, at the usual stage of pregnancy. Others were born early and received specialist care. One trial compared a supplement given to breastfeeding mothers with a supplement given directly to infants. Most studies measured 25-hydroxyvitamin D, a blood substance used to assess vitamin D status.
What did the studies find?
Higher infant doses generally raised the blood measurement. In term infants, this did not consistently produce an added bone benefit. A tested high-maternal-dose strategy produced similar infant blood status to direct infant supplementation among pairs who continued breastfeeding. An intermediate maternal-dose arm was stopped because of infant deficiency.
What does this mean?
A supplement can change a blood result without proving better health. Starting status, feeding circumstances and other nutritional sources matter. A supplement dose is not always the total amount received.
What are the limits?
Some trials were small or lost many participants during follow-up. The studies of infants born early were short. Milk vitamin D was not measured in the maternal-route trial. These studies do not establish one best intake or blood target for every infant. Research doses are not instructions for infant care.
Read the full article below ↓Vitamin D studies in infants measure different things. Some ask whether a supplement changes a blood result. Others ask whether it improves health. This summary explains what six independent trial groups found about vitamin D sources and blood-level changes in infants born at term and infants born early. For the methods, comparisons and limitations, read Infant Vitamin D Sources and Status: Full Evidence Review.
What was the question?
The studies asked how vitamin D status changes with the supplement amount, the infant’s starting status, feeding circumstances and the person receiving the supplement. Most measured 25-hydroxyvitamin D, usually written as 25(OH)D. This is a substance the body produces when it processes vitamin D. It is used to assess vitamin D status. It is different from vitamin D3 in a supplement and from the active vitamin D hormone. These blood markers are explained in Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D, and their conversion in Vitamin D Activation.
A higher blood result does not, by itself, show that an infant has stronger bones or fewer illnesses. The amount assigned as a supplement may also differ from total intake when other feeds supply vitamin D. Research doses are descriptions of experiments, not instructions for an infant’s care. IU means international units.
For current UK guidance, see NHS Vitamins for children. Infants born early need advice from their neonatal team.
What happened in term infants?
In Montreal, Gallo and colleagues studied 132 healthy breastfed infants born at term, meaning at the usual stage of pregnancy. They compared four daily supplement amounts, from 400 to 1,600 IU. Blood-level responses differed, but higher amounts did not show an added growth or bone-mineral benefit. The highest-dose arm was stopped after high results from one laboratory method. Later measurements were lower, and further safety investigations were normal. This was not proof of toxic injury (Gallo et al., 2013).
The Finnish VIDI trial compared 400 with 1,200 IU daily from two weeks to two years. It included 975 infants in the analysis. Most already had sufficient vitamin D status at birth. The higher dose raised blood levels but did not add a detected bone benefit or reduce the overall rate of reported infections (Rosendahl et al., 2018).
A separate Montreal trial selected 98 infants with low vitamin D status at birth and assigned them by chance to two supplement groups. It compared 400 with 1,000 IU daily, starting at about one month. The higher amount raised blood levels without a demonstrated bone-mineral advantage. Another report from the same trial found modestly higher absolute lean mass with the higher dose at 12 months, but no matching improvement in the proportion of lean tissue, lean mass adjusted for length, or fat outcomes. Lean mass includes soft tissue other than fat, including muscle. This does not show stronger muscles or prevention of later obesity (Gharibeh et al., 2023; Razaghi et al., 2022).
Could a maternal supplement affect a breastfed infant’s status?
Hollis and colleagues compared supplementation given to the mother with supplementation given directly to the infant. Among pairs who continued breastfeeding, the tested high-maternal-dose strategy produced infant blood status similar to the direct-infant strategy. An intermediate maternal-dose arm was stopped because infants developed low vitamin D status. Many pairs stopped breastfeeding during follow-up, and milk vitamin D was not measured. The result does not establish that every maternal regimen can replace infant supplementation, or that the strategies have equal clinical benefits and safety (Hollis et al., 2015, corrected 2019).
What happened in preterm infants?
A 2025 trial in Chiang Mai compared supplemental doses of 400 and 800 IU in 38 infants born early or with very low birthweight. The higher-dose group had higher vitamin D status at six weeks of age, after about four to five weeks of treatment. Calcium, phosphate and alkaline phosphatase, a protein that helps chemical reactions, did not show an added benefit. The study did not test improved bone scans or fewer fractures. Other nutrition and mineral care contributed to the infants’ exposure (Rueang-Amnat et al., 2025).
A smaller Nebraska trial also found higher vitamin D status at four weeks with 800 rather than 400 IU. Its later numbers and bone reporting contain disagreements, so those disputed results are not used here (Anderson-Berry et al., 2017).
What does this mean?
Starting status, feeding route, other nutritional sources and prematurity all affect the interpretation. The trials show that different strategies can change infant blood levels. They do not establish one best intake or blood target for every infant. This distinction is explained in Why a Vitamin D Deficiency Threshold Is Not the Same as a Functional Target. Findings from a neonatal unit should not be transferred directly to a healthy term infant at home.
This is a summary of selected assessed studies, not a feeding guideline. The detailed review explains the sources, missing information and differences between trials. The separate outcomes review examines why a changed blood level and a health benefit need different evidence.
Sources
These are the same assessed sources used by the detailed review. Companion papers from one trial do not count as separate experiments. Unavailable supplementary details from the maternal-route and lean-mass papers are not used to make precise safety, subgroup or equivalence claims.
Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial. Correction. Pediatrics. 2019;144:e20191063. Figure 2B/C labels corrected; not a separate trial.
Correction of neonatal vitamin D status using 1000 IU vitamin D/d increased lean body mass by 12 months of age compared with 400 IU/d: a randomized controlled trial. Razaghi M et al. American Journal of Clinical Nutrition. 2022;115:1612 to 1625. Same trial as Gharibeh; the title refers to correcting status, not an erratum.
Randomized trial of two doses of vitamin D3 in preterm infants <32 weeks: Dose impact on achieving desired serum 25(OH)D3 in a NICU population. Anderson-Berry A et al. PLoS ONE. 2017;12:e0185950. DOI: 10.1371/journal.pone.0185950.
Related reading
Nutrient Intakes and Food Sources of Filipino Infants, Toddlers and Young Children are Inadequate: Findings from the National Nutrition Survey 2013
Reported foods and beverages were assigned to one of 85 food groups.
Original paper ↗Read more →Nutritional and Non-nutritional Composition of Human Milk Is Modulated by Maternal, Infant, and Methodological Factors
The objective of this narrative review is to summarize the maternal, infant and methodological factors that affect HM composition.
Original paper ↗Read more →Improving Vitamin D Status in Preterm Newborns: A Randomized Trial of 800 vs. 400 IU/Day
This study aimed to compare the efficacy of two vitamin D3 dosages (400 IU/day vs.
Original paper ↗Read more →Improving Vitamin D Status in Preterm Newborns: A Randomized Trial of 800 vs. 400 IU/Day
This study aimed to compare the efficacy of two vitamin D3 dosages (400 IU/day vs.
Original paper ↗Read more →Randomized trial of two doses of vitamin D3 in preterm infants
32 infants born at 24 to 32 weeks gestation were prospectively randomized to receive 400 or 800 IU/day vitamin D3 supplementation.
Original paper ↗Read more →Sun Exposure and Vitamin D Supplementation in Relation to Vitamin D Status of Breastfeeding Mothers and Infants in the Global Exploration of Human Milk Study
Although vitamin D (vD) deficiency is common in breastfed infants and their mothers during pregnancy and lactation, a standardized global comparison is lacking.
Original paper ↗Read more →Comparison of gut microbiota in exclusively breast-fed and formula-fed babies: a study of 91 term infants
Faecal bacterial composition was tested.
Original paper ↗Read more →Correlation of Maternal Vitamin D Status in Early Pregnancy and Vitamin D Supplementation during Pregnancy with Atopic Dermatitis in Infants: A Prospective Birth Cohort Study
Objective: This study aimed to investigate the association of maternal first-trimester vitamin D levels and vitamin D supplementation during pregnancy with infant atopic dermatitis (AD) and to determine the effect of variables such as mode of conception on the association.
Original paper ↗Read more →Early pregnancy vitamin D and the risk of adverse maternal and infant outcomes: a retrospective cohort study
Previous evidence has suggested that lower gestational vitamin D levels might increase the risks of adverse pregnancy and birth outcomes.
Original paper ↗Read more →Human milk-derived versus bovine milk-derived fortifier use in very low birth weight infants: growth and vitamin D status
Serum 25OHD level in the HMDF group was significantly higher compared with that in the BMDF group at 4 weeks of age despite receiving lower vitamin D supplementation.
Original paper ↗Read more →Micronutrients in infants suffering from cow’s milk allergy fed with dietary formulas and breast milk
As this food allergy indicates a wide range of clinical syndromes due to immunological reactions to cow’s milk proteins, we aimed to evaluate the status of micronutrients in infants suffering from cow’s milk allergy.
Original paper ↗Read more →Nutrient intakes and iron and vitamin D status differ depending on main milk consumed by UK children aged 12 to 18 months: secondary analysis from the Diet and Nutrition Survey of Infants and Young Children
Milk is a major food for young children and this analysis evaluated the impact of the type of milk consumed on nutrient intakes and nutritional status.
Original paper ↗Read more →Trajectories of Dietary Energy, Macro and Micronutrient Intake From the Third Trimester of Pregnancy to 8.5 Months Postpartum Among Brazilian Women: The Mothers, Infants and Lactation Quality Study
This study evaluated the trajectories of maternal dietary energy, macro‐ and micronutrient intake from the third trimester of pregnancy to 8.5 months postpartum, associated factors, and micronutrient intake adequacy.
Original paper ↗Read more →Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy
The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.
Original paper ↗Read more →Review: Influence of 25(OH)D Blood Concentration and Supplementation during Pregnancy on Preeclampsia Development and Neonatal Outcomes
Briefly, 25-hydroxyvitamin D (25(OH)D) plays an essential role in embryogenesis and the course of intra: and postnatal periods and is crucially involved in the functioning of the mother: placenta: fetus system.
Original paper ↗Read more →Basal Vitamin D Status and Supplement Dose Are Primary Contributors to Maternal 25-Hydroxyvitamin D Response to Prenatal and Postpartum Cholecalciferol Supplementation
We aimed to examine interindividual variation in maternal and infant 25(OH)D following maternal vitamin D supplementation.
Original paper ↗Read more →Infant Vitamin D Sources and Status: Full Evidence Review
How infant vitamin D status changes with starting status, feeding route and supplementation: evidence from term and preterm trials, with key limits.
Read more →25(OH)D Concentration in Neonates, Infants, and Toddlers From Poland: Evaluation of Trends During Years 1981 to 2011
The aim of this study was to analyse trends in serum 25-hydroxyvitamin D concentration (25(OH)D) change over the 30 years of operation of a single pediatric diagnostic unit.
Original paper ↗Read more →25(OH)D Concentration in Neonates, Infants, Toddlers, Older Children and Teenagers from Poland: Evaluation of Trends during Years 2014 to 2019
Our study aimed to assess 25(OH)D concentration and its potential change during a growth and maturation period, adding parameters that reflect the risk of hypercalcemia.
Original paper ↗Read more →Association between Suboptimal 25-Hydroxyvitamin D Status and Overweight/Obesity in Infants: A Prospective Cohort Study in China
This study aimed to investigate whether 25-hydroxyvitamin D (25(OH)D) concentrations are correlated to overweight/obesity in infants and to explore a threshold of 25(OH)D.
Original paper ↗Read more →The association between serum 25-hydroxyvitamin D levels and retinopathy of prematurity in preterm infants
This study aimed to investigate the correlation between serum 25-hydroxyvitamin D (25(OH)D) levels and retinopathy of prematurity (ROP) in premature infants one month after birth.
Original paper ↗Read more →Original sources
Vitamins for children
For current UK guidance, see NHS Vitamins for children.
Publication details
For current UK guidance, see NHS Vitamins for children. Infants born early need advice from their neonatal team.
Effect of Different Dosages of Oral Vitamin D Supplementation on Vitamin D Status in Healthy, Breastfed Infants: A Randomized Trial
Published in Gallo S et al. JAMA (2013).
Publication details
Effect of Different Dosages of Oral Vitamin D Supplementation on Vitamin D Status in Healthy, Breastfed Infants: A Randomized Trial. Gallo S et al. JAMA. 2013;309:1785 to 1792. DOI: 10.1001/jama.2013.3404.
Effect of Higher vs Standard Dosage of Vitamin D3 Supplementation on Bone Strength and Infection in Healthy Infants: A Randomized Clinical Trial
Published in Rosendahl J et al. JAMA Pediatrics (2018).
Publication details
Effect of Higher vs Standard Dosage of Vitamin D3 Supplementation on Bone Strength and Infection in Healthy Infants: A Randomized Clinical Trial. Rosendahl J et al. JAMA Pediatrics. 2018;172:646 to 654. DOI: 10.1001/jamapediatrics.2018.0602.
Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial
Published in Hollis BW et al. Pediatrics (2015).
Publication details
Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial. Hollis BW et al. Pediatrics. 2015;136:625 to 634. DOI: 10.1542/peds.2015-1669. Principal report assessed from an institutional full-text copy.
Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial
Published in Correction. Pediatrics (2019).
Publication details
Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial. Correction. Pediatrics. 2019;144:e20191063. Figure 2B/C labels corrected; not a separate trial.
Effect of Vitamin D Supplementation on Bone Mass in Infants With 25-Hydroxyvitamin D Concentrations Less Than 50 nmol/L: A Prespecified Secondary Analysis of a Randomized Clinical Trial
Published in Gharibeh N et al. JAMA Pediatrics (2023).
Publication details
Effect of Vitamin D Supplementation on Bone Mass in Infants With 25-Hydroxyvitamin D Concentrations Less Than 50 nmol/L: A Prespecified Secondary Analysis of a Randomized Clinical Trial. Gharibeh N et al. JAMA Pediatrics. 2023;177:353 to 362. DOI: 10.1001/jamapediatrics.2022.5837.
Correction of neonatal vitamin D status using 1000 IU vitamin D/d increased lean body mass by 12 months of age compared with 400 IU/d: a randomized controlled trial
Published in Razaghi M et al. American Journal of Clinical Nutrition (2022).
Publication details
Correction of neonatal vitamin D status using 1000 IU vitamin D/d increased lean body mass by 12 months of age compared with 400 IU/d: a randomized controlled trial. Razaghi M et al. American Journal of Clinical Nutrition. 2022;115:1612 to 1625. Same trial as Gharibeh; the title refers to correcting status, not an erratum.
Improving Vitamin D Status in Preterm Newborns: A Randomized Trial of 800 vs. 400 IU/Day
Published in Rueang-Amnat N et al. Nutrients (2025).
Publication details
Improving Vitamin D Status in Preterm Newborns: A Randomized Trial of 800 vs. 400 IU/Day. Rueang-Amnat N et al. Nutrients. 2025;17:1888. DOI: 10.3390/nu17111888.